Brief: Nanobiotix SA Says H1 Net Loss Attributable To Common Shareholders Was EUR 28.1 Million, Or EUR 0.80 Per Share

Nanobiotix SA

26/09/2023 21:18

Sept 26 (Reuters) - Nanobiotix SA  NANOB.PA :
    * PROVIDES BUSINESS UPDATE AND FINANCIAL RESULTS FOR FIRST
HALF OF
2023
    * REPORTED EUR 21.6 MILLION IN CASH AND CASH EQUIVALENTS AS
OF
JUNE 30, 2023
    * NET LOSS ATTRIBUTABLE TO COMMON SHAREHOLDERS FOR SIX
MONTHS
ENDED JUNE 30, 2023 WAS EUR 28.1 MILLION, OR EUR 0.80 PER SHARE
    * NANOBIOTIX - H1 REVENUE AND OTHER INCOME HAS INCREASED TO
EUR
3.3 MILLION VERSUS EUR 1.3 MILLION

Source text for Eikon:  ID:nGNE6m3shj 
Further company coverage:  NANOB.PA 

 ((Reuters.Briefs@thomsonreuters.com;))